These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 5957992

  • 1. Growth of subcutaneous grafts of some clones of Ehrlich ascites tumor in mice of different strains.
    Bregula U, Slowikowska G, Dux K.
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):711-6. PubMed ID: 5957992
    [No Abstract] [Full Text] [Related]

  • 2. Dynamics of growth and regression of Ehrlich ascites carcinoma transplanted intraperitoneally in rats.
    Janik P, Dabrowski M, Dux K.
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):717-23. PubMed ID: 5957993
    [No Abstract] [Full Text] [Related]

  • 3. Effect of subcutaneous transplants of Ehrlich carcinoma on the survival time of mice with intraperitoneal transplants of the same tumour.
    Hartveit F, Halleraker B.
    J Pathol; 1971 Oct; 105(2):85-93. PubMed ID: 5135341
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of the survival of skin grafts from normal mice and mice with Ehrlich ascites tumor.
    Hur NB, Biran S, Robinson E.
    Transplantation; 1966 Mar; 4(2):205-6. PubMed ID: 5326924
    [No Abstract] [Full Text] [Related]

  • 5. Rejection of lethal tumors after subcutaneous inoculation: a phenomenon of antigenic expression?
    Apffel CA, Peters JH.
    J Natl Cancer Inst; 1967 Dec; 39(6):1129-39. PubMed ID: 4170428
    [No Abstract] [Full Text] [Related]

  • 6. Acquired immunity to Ehrlich ascites tumor in mice after treatment with fresh or sonized tumor cells at various ages.
    Yasuhira K.
    Acta Tuberc Jpn; 1966 Dec; 16(2):78-84. PubMed ID: 5984181
    [No Abstract] [Full Text] [Related]

  • 7. Resistance to Ehrlich ascites tumor in a strain of dystrophic mice.
    Carry PJ, Prescott DM, Ogilvie GK.
    Cancer Res; 1979 Jun; 39(6 Pt 1):2139-40. PubMed ID: 445411
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of the growth of the Ehrlich ascites tumor in male and female mice.
    Vincent PC, Nicholls A.
    Cancer Res; 1967 Jun; 27(6):1058-65. PubMed ID: 6027198
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The modelling of the growth of Ehrlich carcinoma and teratoma T-36 with ascitic fluid and tumor-cell dialysate].
    Donenko FV, Kabieva AO, Moroz LV.
    Biull Eksp Biol Med; 1992 Jul; 114(8):193-5. PubMed ID: 1467492
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The antitumor action of bacterial extract. I. Suppression of mouse ascites tumors by the treatments with extracts of E. coli.
    Watanabe T.
    Jpn J Exp Med; 1969 Dec; 39(6):631-47. PubMed ID: 4914751
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of growth of Ehrlich ascites tumors in ICR-Ha Swiss mice by isocyanates.
    Moos GE, Maguire JA, Kitchlew TZ, Swyers WA, Volk PZ, Croft JR, Quigley MJ, Fries JR, Oser NA, Anderson LJ.
    Cancer Res; 1971 Jul; 31(7):937-41. PubMed ID: 5560387
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.